{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:38:53Z","timestamp":1793619533917,"version":"4.5.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2616,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1111\/j.1469-0691.2007.01781.x","type":"journal-article","created":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T04:56:54Z","timestamp":1185425814000},"page":"953-963","source":"Crossref","is-referenced-by-count":103,"title":["Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system"],"prefix":"10.1016","volume":"13","author":[{"given":"C.","family":"Steininger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01781.x_bib1","series-title":"Cytomegaloviruses and their replication","first-page":"2447","author":"Mocarski","year":"1996"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib2","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/JCM.43.9.4713-4718.2005","article-title":"Diagnosis of and screening for cytomegalovirus infection in pregnant women","volume":"43","author":"Munro","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9343(87)90105-7","article-title":"Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell\u2010mediated immunity","volume":"82","author":"Collier","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.7326\/0003-4819-100-2-213","article-title":"Heterosexual and homosexual patients with the acquired immunodeficiency syndrome. A comparison of surveillance, interview, and laboratory data","volume":"100","author":"Guinan","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib5","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1086\/374739","article-title":"The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14\u2010month longitudinal study","volume":"187","author":"Ling","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib6","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/317624","article-title":"Reactivation and shedding of cytomegalovirus in astronauts during spaceflight","volume":"182","author":"Mehta","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CMR.13.1.83-121.2000","article-title":"New strategies for prevention and therapy of cytomegalovirus infection and disease in solid\u2010organ transplant recipients","volume":"13","author":"Sia","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10096-004-1160-2","article-title":"Retinal and extraocular cytomegalovirus end\u2010organ disease in HIV\u2010infected patients in Europe: a EuroSIDA study, 1994\u20132001","volume":"23","author":"Yust","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00007890-198309000-00007","article-title":"Early infections in kidney, heart, and liver transplant recipients on cyclosporine","volume":"36","author":"Dummer","year":"1983","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-3062.2000.020303.x","article-title":"Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis","volume":"2","author":"Rubin","year":"2000","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib11","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.tp.0000230460.42558.b0","article-title":"The natural course of cytomegalovirus infection and disease in renal transplant recipients","volume":"82","author":"Hartmann","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/13550289809113490","article-title":"Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis","volume":"4","author":"Cinque","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/clinids\/22.3.537","article-title":"Cytomegalovirus infection following liver transplantation: review of the literature","volume":"22","author":"Kanj","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib15","first-page":"7","article-title":"Advances in understanding cytomegalovirus infection after transplantation","volume":"26","author":"Ho","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.10.1.86","article-title":"Infections in solid\u2010organ transplant recipients","volume":"10","author":"Patel","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib17","first-page":"208","article-title":"HIV\/AIDS and blindness","volume":"79","author":"Kestelyn","year":"2001","journal-title":"Bull WHO"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(00)00356-1","article-title":"Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy","volume":"129","author":"Nguyen","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archopht.116.2.169","article-title":"Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome","volume":"116","author":"Karavellas","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0002-9394(99)80134-2","article-title":"Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis","volume":"125","author":"Zegans","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0966-842X(98)01255-4","article-title":"Immune evasion by cytomegalovirus\u2014survival strategies of a highly adapted opportunist","volume":"6","author":"Hengel","year":"1998","journal-title":"Trends Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0041-1345(98)00547-8","article-title":"Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease","volume":"30","author":"Waiser","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1164\/ajrccm.150.1.8025741","article-title":"A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation","volume":"150","author":"Duncan","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib24","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1086\/515383","article-title":"Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients","volume":"178","author":"Roberts","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib25","first-page":"960","article-title":"The association of increased soluble VCAM\u20101 levels with CMV disease in human kidney allograft recipients","volume":"27","author":"Lebranchu","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib26","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1046\/j.1523-1755.2000.00438.x","article-title":"Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM\u20101 in blood","volume":"58","author":"Kas\u2010Deelen","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib27","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/s00125-004-1499-z","article-title":"Asymptomatic cytomegalovirus infection is associated with increased risk of new\u2010onset diabetes mellitus and impaired insulin release after renal transplantation","volume":"47","author":"Hjelmesaeth","year":"2004","journal-title":"Diabetologia"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(97)80021-6","article-title":"The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG\u2010Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland","volume":"103","author":"George","year":"1997","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib30","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1161\/01.CIR.92.9.2594","article-title":"Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection","volume":"92","author":"Lemstrom","year":"1995","journal-title":"Circulation"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(89)90312-7","article-title":"Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection","volume":"ii","author":"Webster","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib32","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1086\/315476","article-title":"Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia","volume":"181","author":"Sabin","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S095026880005799X","article-title":"The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion","volume":"114","author":"Sabin","year":"1995","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00002030-200101260-00016","article-title":"Cytomegalovirus seroconversion as a cofactor for progression to AIDS","volume":"15","author":"Robain","year":"2001","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1086\/427509","article-title":"Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis","volume":"40","author":"Snydman","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib36","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/425002","article-title":"The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients","volume":"39","author":"Munoz\u2010Price","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","article-title":"Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo\u2010controlled study","volume":"100","author":"Valantine","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib38","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(97)05535-9","article-title":"Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver\u2010transplant recipients. The Oral Ganciclovir International Transplantation Study Group","volume":"350","author":"Gane","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta\u2010analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2007.01781.x_bib40","first-page":"S37","article-title":"Lessons from the natural history of cytomegalovirus","volume":"10","author":"Bowen","year":"1996","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archopht.1989.01070010077031","article-title":"Cytomegalovirus retinitis and acquired immunodeficiency syndrome","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib42","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J AIDS"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib43","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/14.2.608-a","article-title":"Cytomegalovirus infection in patients with AIDS","volume":"14","author":"Drew","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib44","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJM199312233292604","article-title":"Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study","volume":"329","author":"Hoover","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib45","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib46","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/314943","article-title":"Decrease of cytomegalovirus replication in human immunodeficiency virus infected\u2010patients after treatment with highly active antiretroviral therapy","volume":"180","author":"O'Sullivan","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib47","first-page":"37","article-title":"Changing trends in cytomegalovirus disease in HIV\u2010infected patients","volume":"8","author":"Deayton","year":"2001","journal-title":"Herpes"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200102160-00008","article-title":"Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis","volume":"15","author":"Detels","year":"2001","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib49","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS\u2010related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0140-6736(00)02504-6","article-title":"AIDS across Europe, 1994\u201398: the EuroSIDA study","volume":"356","author":"Mocroft","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157489107779561634","article-title":"Novel therapies for cytomegalovirus disease","volume":"2","author":"Steininger","year":"2007","journal-title":"Recent Patents Anti-Infective Drug Discovery"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib52","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1128\/JVI.66.12.7146-7152.1992","article-title":"Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents","volume":"66","author":"Lurain","year":"1992","journal-title":"J Virol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/359085a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus\u2010infected cells","volume":"359","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib54","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1128\/JVI.68.7.4427-4431.1994","article-title":"Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir","volume":"68","author":"Lurain","year":"1994","journal-title":"J Virol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/AAC.37.1.19","article-title":"A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives","volume":"37","author":"Sullivan","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib56","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archopht.1996.01100140023002","article-title":"Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group","volume":"114","author":"Jabs","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00007890-200001150-00032","article-title":"Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient","volume":"69","author":"Bienvenu","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib58","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir\u2010resistant cytomegalovirus disease among recipients of solid\u2010organ transplants","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral\u2010drug resistance among patients recently infected with HIV","volume":"347","author":"Little","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib60","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00002030-200005260-00017","article-title":"Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy","volume":"14","author":"Salmon\u2010Ceron","year":"2000","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib61","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bjo.83.6.652","article-title":"Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study","volume":"83","author":"Mitchell","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS\u2010related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib63","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1001\/archinte.163.18.2187","article-title":"CD4 T\u2010lymphocyte recovery in individuals with advanced HIV\u20101 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study","volume":"163","author":"Kaufmann","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib64","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1378\/chest.120.6.1888","article-title":"Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy","volume":"120","author":"Wolff","year":"2001","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib65","first-page":"29","article-title":"Detection of human cytomegalovirus and analysis of strain variation","volume":"49","author":"Huang","year":"1976","journal-title":"Yale J Biol Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.36.1.152-161.1980","article-title":"DNA nucleotide sequence heterogeneity between the Towne and AD169 strains of cytomegalovirus","volume":"36","author":"Pritchett","year":"1980","journal-title":"J Virol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/infdis\/160.1.11","article-title":"Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors","volume":"160","author":"Chou","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0042-6822(81)90641-3","article-title":"Immediate\u2010early proteins of human cytomegalovirus strains AD169, Davis, and Towne differ in electrophoretic mobility","volume":"112","author":"Gibson","year":"1981","journal-title":"Virology"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib69","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/infdis\/150.6.952","article-title":"Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization","volume":"150","author":"Drew","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib70","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1099\/0022-1317-67-10-2179","article-title":"Comparison of restriction site polymorphisms among clinical isolates and laboratory strains of human cytomegalovirus","volume":"67","author":"Chandler","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib71","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/infdis\/162.3.738","article-title":"Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens","volume":"162","author":"Chou","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib72","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/367900","article-title":"Inter\u2010 and intragenic variations complicate the molecular epidemiology of human cytomegalovirus","volume":"187","author":"Rasmussen","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000150510","article-title":"Human cytomegalovirus glycoproteins","volume":"39","author":"Britt","year":"1996","journal-title":"Intervirology"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib74","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib75","first-page":"121","article-title":"Vaccination against cytomegalovirus","volume":"17","author":"Plotkin","year":"2001","journal-title":"Arch Virol Suppl"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/rmv.315","article-title":"A review of genetic differences between limited and extensively passaged human cytomegalovirus strains","volume":"11","author":"Prichard","year":"2001","journal-title":"Rev Med Virol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib77","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315022","article-title":"A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant","volume":"180","author":"Pass","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00006454-200202000-00009","article-title":"Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers","volume":"21","author":"Mitchell","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib79","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00006454-199803000-00006","article-title":"Safety and immunogenicity of the Towne strain cytomegalovirus vaccine","volume":"17","author":"Adler","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib80","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1517\/14712598.1.3.401","article-title":"Development of a cytomegalovirus vaccine: lessons from recent clinical trials","volume":"1","author":"Gonczol","year":"2001","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","article-title":"Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age","volume":"171","author":"Adler","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib82","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/infdis\/163.6.1229","article-title":"Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization\u2010related epitopes","volume":"163","author":"Chou","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib83","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1993.1192","article-title":"Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate","volume":"193","author":"Compton","year":"1993","journal-title":"Virology"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib84","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1086\/515672","article-title":"Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis","volume":"178","author":"Chern","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib85","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1128\/JCM.41.7.2872-2877.2003","article-title":"Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR","volume":"41","author":"Tarrago","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib86","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1128\/JVI.63.5.1995-2001.1989","article-title":"Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus","volume":"63","author":"Utz","year":"1989","journal-title":"J Virol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib87","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/aid.1998.14.533","article-title":"Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1\u20134 in immunocompromised patients","volume":"14","author":"Zipeto","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib88","first-page":"745","article-title":"Subtyping of cytomegalovirus strains obtained from immunocompetent children","volume":"14","author":"Numazaki","year":"2000","journal-title":"In Vivo"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib89","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/175.3.533","article-title":"The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein\u2010specific antibodies","volume":"175","author":"Schoppel","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib90","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/377002","article-title":"Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid\u2010organ\u2010transplant recipients with CMV disease","volume":"188","author":"Humar","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib91","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/421496","article-title":"Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients","volume":"39","author":"Coaquette","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib92","first-page":"540","article-title":"Seroepidemiologic studies of cytomegalovirus and Epstein\u2013Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group","volume":"2","author":"Lang","year":"1989","journal-title":"J AIDS"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib93","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/00365549609037937","article-title":"Glycoprotein B genotype of human cytomegalovirus: distribution in HIV\u2010infected patients","volume":"28","author":"Bongarts","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib94","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/infdis\/150.6.953","article-title":"Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome","volume":"150","author":"Spector","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib95","first-page":"273","article-title":"Cytomegalovirus genotypes present in cerebrospinal fluid of HIV\u2010infected patients","volume":"19","author":"Steininger","year":"2005","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib96","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1099\/0022-1317-80-6-1495","article-title":"Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination","volume":"80","author":"Haberland","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib97","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.tp.0000245676.43979.86","article-title":"A review of critical periods for opportunistic infection in the new transplantation era","volume":"82","author":"Garrido","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib98","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1034\/j.1600-6143.2003.00140.x","article-title":"Cytomegalovirus disease in high\u2010risk transplant recipients despite ganciclovir or valganciclovir prophylaxis","volume":"3","author":"Akalin","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib99","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T\u2010cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib100","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1086\/322663","article-title":"Late and atypical cytomegalovirus disease in solid\u2010organ transplant recipients","volume":"33","author":"Slifkin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib101","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0041-1345(03)00088-5","article-title":"Late cytomegalovirus infection occurring two or more years following liver transplantation: a report of seven cases and review of the literature","volume":"35","author":"Shibolet","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib102","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA\u2010restricted cytomegalovirus (CMV)\u2010specific T\u2010cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib103","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/infdis\/149.5.750","article-title":"Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment","volume":"149","author":"Wade","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib104","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/00007890-200010270-00008","article-title":"Long\u2010term oral ganciclovir prophylaxis for prevention of cytomegalovirus infection and disease in cytomegalovirus high\u2010risk renal transplant recipients","volume":"70","author":"Kletzmayr","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib105","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1086\/424677","article-title":"Antibody maturation and viremia after primary cytomegalovirus infection, in immunocompetent patients and kidney\u2010transplant patients","volume":"190","author":"Steininger","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib106","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1086\/427506","article-title":"Late\u2010onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib107","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/rmv.514","article-title":"The case for cytomegalovirus prophylaxis in solid organ transplantation","volume":"16","author":"Snydman","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib108","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7326\/0003-4819-120-5-199403010-00004","article-title":"High\u2010dose acyclovir compared with short\u2010course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial","volume":"120","author":"Singh","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib109","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00007890-199712270-00036","article-title":"Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients","volume":"64","author":"Brennan","year":"1997","journal-title":"Transplantation"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2007.01781.x_bib110","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain\u2013Barre syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib111","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-199606000-00004","article-title":"The immunopathogenesis of multiple sclerosis and Guillain\u2013Barre syndrome","volume":"9","author":"Giovannoni","year":"1996","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib112","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain\u2013Barre syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","article-title":"Infectious origins of, and molecular mimicry in, Guillain\u2013Barre and Fisher syndromes","volume":"1","author":"Yuki","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"suppl","key":"10.1111\/j.1469-0691.2007.01781.x_bib114","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ana.410090709","article-title":"Role of infection in Guillain\u2013Barr\u00e9 syndrome: laboratory confirmation of herpesviruses in 41 cases","volume":"9","author":"Dowling","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib115","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case\u2010control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib116","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jnnp.51.5.613","article-title":"A prospective study of acute idiopathic neuropathy. II. Antecedent events","volume":"51","author":"Winer","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib117","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/382192","article-title":"Presence of cytomegalovirus in cerebrospinal fluid of patients with Guillain\u2013Barre syndrome","volume":"189","author":"Steininger","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib118","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1212\/WNL.47.3.668","article-title":"Cytomegalovirus infection and Guillain\u2013Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain\u2013Barre Study Group","volume":"47","author":"Visser","year":"1996","journal-title":"Neurology"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib119","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jneuroim.2006.11.006","article-title":"Primary cytomegalovirus infection in patients with Guillain\u2013Barre syndrome","volume":"183","author":"Steininger","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1469-0691.2007.01781.x_bib120","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/314939","article-title":"Asymptomatic primary cytomegalovirus infection: virologic and immunologic features","volume":"180","author":"Zanghellini","year":"1999","journal-title":"J Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14620991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14620991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T10:28:41Z","timestamp":1587810521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14620991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":120,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1198743X14620991"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01781.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}